[1] Ch. P(2010) Vol Ⅱ(中国药典2010年版. 二部)[S]. 2010:84-85.[2] LANGENBUCHER F, BENZ D, KURTH W, et al. Standardized flow-cell method as an alternative to existing pharmacopoeial dissolution testing[J]. Pharm Ind, 1989, 51(11):1276-1281.[3] LANGENBUCHER F, BENZ D, RTH K U W, et al. Standardized flow-cell method as an alternative to existing pharmacopoeial dissolution testing[J]. Pharm Ind, 1989, 51(11):1276-1281.[4] GROVES M J, ALKAN M H, DEER M A. The evaluation of a column-type dissolution apparatus[J]. J Pharmacy Pharm, 1975, 27(6):400-407.[5] LERK C F, ZUURMAN K. The influence of pulsation on the dissolution rate measurements in column type apparatus[J]. J Pharmacy Pharm, 1970, 22(4):319-320.[6] AZARMI S, ROA W, BENBERG L O R. Current perspectives in dissolution testing of conventional and novel dosage forms[J]. Int J Pharm, 2007, 328(1):12-21.[7] FOTAKI N. Flow-through cell apparatus (USP Apparatus 4):Operation and features[J]. Dissol Technol, 2011, 18(4):46-49.[8] SINGH I, ABOUL-ENEIN H Y. Advantages of USP Apparatus IV (flow-through cell apparatus) in dissolution studies[J]. J Iran Chem Soc, 2006, 3(3):220-222.[9] GAO Z. In Vitro Dissolution testing with flow-through method:A technical note[J]. AAPS Pharm Sci Tech, 2009, 10(4):1401-1405.[10] SUN Y. Flow-through cell dissolution test for release control of preparations:in vivo-in vitro correlation of results and prospect of application [J]. Tianjin Pharm(天津药学), 2010, (5):53-57.[11] QIU J X, WU X M. Exploration of Autocorrelation and Heteroscedasticity in Weibull Dissolution Parameter Estimation Base on OLS[J]. J China Pharm (中国药房), 2013, 24(1):37-39.[12] HU J, KYAD A, KU V, et al. A comparison of dissolution testing on lipid soft gelatin capsules using USP apparatus 2 and apparatus 4[J]. Dissolution Technologies, 2005, 12:6-9.[13] BHARDWAJ U, BURGESS D J. A novel USP apparatus 4 based release testing method for dispersed systems[J]. Int J Pharm, 2010, 388(1-2):287-294.[14] BEYSSAC E, LAVIGNE J. Dissolution study of active pharmaceutical ingredients using the flow through apparatus USP 4[J]. Dissolution Technologies, 2005, 12(2):23-25.[15] MER KAJ, STIPPLER E. Experiences with USP Apparatus 4 calibration[J]. Dissolution Technologies, 2005, 12(2):33-39.[16] CHATTARAJ S C, KANFER I. Release of acyclovir from semi-solid dosage forms:A semi-automated procedure using a simple plexiglass flow-through cell[J]. Int J Pharm, 1995, 125(2):215-222.[17] D′ARCY D M, LIU B, BRADLEY G, et al. Hydrodynamic and species transfer simulations in the USP 4 dissolution apparatus:considerations for dissolution in a low velocity pulsing flow[J]. Pharm Res, 2010, 27(2):246-258.[18] ZHANG N, FENG X M, et al. Primary discuss on flow-cell elution release test method at stability of rapamycin on drug-eluting stents[J]. Chin J Pharm Anal (药物分析杂志), 2012, 4:575-577.[19] EATON J W, TRAN D, HAUCK W W, et al. Development of a performance verification test for USP Apparatus 4[J]. Pharm Res, 2012, 29(2):345-351.[20] ZOLNIK B S, RATON J L, BURGESS D J. Application of USP apparatus 4 and in situ fiber optic analysis to microsphere release testing[J]. Dissolution Technologies, 2005, 12(2):11-14.[21] PRABHU N B, MARATHE A S, JAIN S, et al. Comparison of dissolution profiles for sustained release resinates of BCS class I drugs using USP Apparatus 2 and 4:A technical note[J]. AAPS Pharm Sci Tech, 2008, 9(3):769.[22] HURTADO Y D L P, VARGAS A Y, DOMINGUEZ-RAMIREZ A M, et al. Comparison of dissolution profiles for albendazole tablets using USP Apparatus 2 and 4[J]. Drug Dev Ind Pharm, 2003, 29(7):777-784.[23] SUN Y, TANG S F. Determination of Release Rate of Nicotine Sustained-release Patches by Flow-through Cell Method[J]. J China Pharm (中国药房), 2012(33):3133-3135.[24] SUN Y, TANG S F, GAO L Q. Dissolution testing of enalaprilmaleate tables with flowing-through cell method and evaluation of in vivo-in vitro correlation[J]. Chin J Pharm Anal(药物分析杂志), 2009, 4(29):560-563.[25] ZUO P L, WANG A P, LIU W C. Method for In Vitro Release of Rotigotine Microspheres[J]. Chin J Spectr Lab (光谱实验室), 2011(04):2025-2027.[26] TAI X L, LI J H, CH Y, et al. Comparison of Dissolution of Compound Ketoconazole Cream in Vitro from Five Different Pharmaceutical Factories[J]. Chin Pharm Aff(中国药事), 2009(05):474-476.[27] BHATTACHAR S N, WESLEY J A, FIORITTO A, et al. Dissolution testing of a poorly soluble compound using the flow-through cell dissolution apparatus[J]. Int J Pharm, 2002, 236(1-2):135-143.[28] HENG D, CUTLER D J, CHAN H, et al. What is a suitable dissolution method for drug nanoparticles[J]. Pharm Res, 2008, 25(7):1696-1701.[29] DOROZYNSKI P P, KULINOWSKI P, MENDYK A, et al. Novel application of MRI technique combined with flow-through cell dissolution apparatus as supportive discriminatory test for evaluation of controlled release formulations[J]. AAPS Pharm Sci Tech, 2010, 11(2):588-597.[30] RAWAT A, BURGESS D J. USP Apparatus 4 method for in vitro release testing of protein loaded microspheres[J]. Int J Pharm, 2011, 409(1-2):178-184.[31] MUSIAL W, MIELCK J B. The application of modified flow-through cell apparatus for the assessment of chlorhexidine dihydrochloride release from lozenges containing sorbitol[J]. AAPS Pharm Sci Tech, 2009, 10(3):1048-1057.[32] RAWAT A, STIPPLER E, SHAH V P, et al. Validation of USP apparatus 4 method for microsphere in vitro release testing using risperdal consta[J]. Int J Pharm, 2011, 420(2):198-205.[33] FANG J B, ROBERTSON V K, RAWAT A, et al. Development and application of a biorelevant dissolution method using USP Apparatus 4 in early phase formulation development[J]. Mol Pharm, 2010, 7(5):1466-1477.[34] KULINOWSKI P, YSKI P A D, YNARCZYK A M, et al. Magnetic resonance imaging and image analysis for assessment of HPMC matrix tablets structural evolution in USP Apparatus 4[J]. Pharm Res, 2011, 28(5):1065-1073.[35] SHIKO G, GLADDEN L F, SEDERMAN A J, et al. MRI Studies of the hydrodynamics in a USP 4 dissolution testing cell[J]. J Pharm Sci, 2011, 100(3):976-991.[36] ZHANG Q, GLADDEN L, AVALLE P, et al. In vitro quantitative 1H and 19F nuclear magnetic resonance spectroscopy and imaging studies of Fluvastatin^TM in Lescol XL tablets in a USP-IV dissolution cell[J]. J Controlled Release, 2011, 156(3):345-354.[37] ARCY D D M, LIU B, CORRIGAN O I. Investigating the effect of solubility and density gradients on local hydrodynamics and drug dissolution in the USP 4 dissolution apparatus[J]. Int J Pharm, 2011, 419(1):175-185.[38] FYFE C A, GRONDEY H, BLAZEK-WELSH A I, et al. NMR Imaging investigations of drug delivery devices using a flow-through USP dissolution apparatus[J]. J Controlled Release, 2000, 68(1):73-83.[39] BIELEN N. Performance of USP calibrator tablets in flow-through cell apparatus[J]. Int J Pharm, 2002, 233(1-2):123-129.[40] FOTAKI N, AIVALIOTIS A, BUTLER J, et al. A comparative study of different release apparatus in generating in vitro-in vivo correlations for extended release formulations[J]. Eur J Pharm Biopharm, 2009, 73(1):115-120.[41] SCHULTZ P, KLEINEBUDDE P. A new multiparticulate delayed release system.:Part I:Dissolution properties and release mechanism[J]. J Controlled Release, 1997, 47(2):181-189.[42] GAO Z, WESTENBERGER B. Dissolution testing of acetaminophen suspension using dialysis adapter in flow-through apparatus:A technical note[J]. AAPS Pharm Sci Tech, 2012, 13(3):944-948.[43] SIEVENS-FIGUEROA L, PANDYA N, BHAKAY A, et al. Using USP I and USP IV for discriminating dissolution rates of nano-and microparticle-loaded pharmaceutical strip-films[J]. AAPS Pharm Sci Tech, 2012, 13(4):1473-1482.[44] EMARA L H, ABDOU A R, EL-ASHMAWY A A, et al. In vitro release evaluation of gastroretentive amoxicillin floating tablets employing a specific design of the flow-through cell[J]. Dissolution Technologies, 2013, 20(1):27-34.[45] BROWNE D C, KIESELMANN S. Low-level drug release-rate testing of ocular implants using USP Apparatus 4 dissolution and HPLC end analysis[J]. Dissolution Technologies, 2010, 17(1):12-14.[46] SUGAWARA M, KADOMURA S, HE X, et al. The use of an in vitro dissolution and absorption system to evaluate oral absorption of two weak bases in pH-independent controlled-release formulations[J]. Eur J Pharm Sci, 2005, 26(1):1-8.[47] HE X, KADOMURA S, TAKEKUMA Y, et al. A new system for the prediction of drug absorption using a pH-controlled Caco-2 model:Evaluation of pH-dependent soluble drug absorption and pH-related changes in absorption[J]. J Pharm Sci, 2004, 93(1):71-77.[48] HE X, SUGAWARA M, KOBAYASHI M, et al. An in vitro system for prediction of oral absorption of relatively water-soluble drugs and ester prodrugs[J]. Int J Pharm, 2003, 263(1):35-44.[49] KOBAYASHI M, SADA N, SUGAWARA M, et al. Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract[J]. Int J Pharm, 2001, 221(1):87-94.[50] LI Z Q, LIU ZH D, G H, et al. Evaluation on the release discipline of salvianolic acid B sustained-release tablets using a drug dissolution and absorption simulating system[J]. Drug Eval Res(药物评价研究), 2010(5):367-373.